Stock Updates

Abbott Laboratories (NYSE: ABT) – Is this large market cap stock undervalued?

Abbott Laboratories (NYSE: ABT), is firmly in the large market cap category with market cap of 60240.6. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Abbott Laboratories is 40.86 (with a change from open of 0.29%), this in conjunction with a target price of 7.09. Volume today has so far reached 3261104, with an average volume of about 9292.27. The GAP for this stock, is -0.59%.

The P/E ratio is 31.45, bringing the forward P/E to a value of 16.73. The current EPS for Abbott Laboratories, is 1.3, with a EPS growth for this year coming to a value of 53.50%. Performance has been interesting with performance year to date coming to -6.45%.

Looking further into the growth statistics for Abbott Laboratories, EPS is looking like it will grow 11.42% in the next year. Looking even further it is projected to be 9.61%. Quarter over quarter is -22.60% for EPS growth and for sales growth quarter over quarter it is 3.20%. Looking at past EPS growth statistics we see that for the past five years it has been -10.30%. Sales growth for the past five years has in fact been -10.30%.

Looking at the ownership, we see that the insider ownership is at 0.30% and institutional ownership is 73.80%. Shares outstanding is 1470, while shares float is at a value of 1465.07. Float short for Abbott Laboratories is 4.62% and the short ratio is 7.29.

In terms of debt, long term debt/equity is 0.29, while the total debt/equity comes to 0.41. The ability to meet these debts, means that the current ratio is 1.5, and the quick ratio is 1.2. The most recent gross margin is 56.90% and their operating margin is 14.00%. The profit margin is 11.10%.

Abbott Laboratories has seen returns on assets of 5.60%, and on investment, 7.70%. Return on equity is 10.90%. Price/Earnings to growth ratio is 3.27. Price/Sales ratio is at a value of 2.93, with Price/book ratio coming to 2.92 and Price/cash is 13.57, and finally Price/Free cash Flow is 298.22.

The simple moving averages are -4.13% and 1.17% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -10.20% and the 52 week low is 15.63%.

Abbott Laboratories has a dividend yield of 2.54%, with a current price of 40.86. The ability to pay this means the payout ratio is 66.50%. This is in an industry, Medical Appliances & Equipment, with equally high dividends from other companies in this sector, which it is Healthcare. Abbott Laboratories is based in USA.

Performance in the Medical Appliances & Equipment industry means that Abbott Laboratories has seen performance for the past week of -3.51%, with performance for the month coming to 1.48%. Looking at the data for the quarter it is at a value of -2.46%, and for the half year the performance is 2.67%. Volatility for this week is 2.47% and for the month this is 1.82%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment